Two Sigma Securities’s Humacyte Inc Warrant HUMAW Stock Holding History
Bought
Maintained
Sold
Other funds holding HUMAW
SCM
WAM
Two Sigma Securities's HUMAW Position: Q1 2026 in Review
Two Sigma Securities reduced its Humacyte Inc Warrant (HUMAW) stake by 7.1% in Q1 2026, selling an estimated $368 and leaving 42,124 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1530.
Two Sigma Securities first reported a position in HUMAW in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.25K in Q4 2025. 7 funds tracked by Wall St. Rank hold HUMAW as of Q1 2026.
- Two Sigma Securities held 42,124 shares of Humacyte Inc Warrant worth $3.85K as of Q1 2026.
- Two Sigma Securities sold 3,218 Humacyte Inc Warrant shares in Q1 2026, an estimated $368.
- Humacyte Inc Warrant made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1530 holding.
- Two Sigma Securities first reported a position in Humacyte Inc Warrant in Q4 2025 and has held it in 2 quarters since.
- Two Sigma Securities's Humacyte Inc Warrant position peaked at $4.25K in Q4 2025.
- 7 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.